GoodRx Holdings Current Cash

The latest current cash for GDRX is $240M as of March 2026. That compares with $300M in the prior-year period — down 21.7% year over year. Investors often review this figure alongside GoodRx Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, GDRX's current cash moved from $300M to $240M — a 21.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in GoodRx Holdings's operating scale or balance-sheet position.

A current cash figure of $240M for GDRX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GDRX's current cash ($240M), review year-over-year change from $300M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack GoodRx Holdings's current cash against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.